Clinical Trials on Dyslipidemia in Australia
Total 110 results
-
AmgenCompletedPrimary Hyperlipidemia and Mixed DyslipidemiaAustralia
-
Chong Kun Dang PharmaceuticalCompleted
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, Australia, United States
-
AstraZenecaCompletedMetabolic Syndrome | DyslipidemiaAustralia
-
Orient Pharma Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed DyslipidemiasTaiwan, Australia, New Zealand
-
Silence Therapeutics plcMedpace, Inc.CompletedDyslipidemias | Hyperlipidemias | Elevated Lp(a)United States, Australia, United Kingdom, Netherlands
-
The University of Western AustraliaCompletedObesity | Insulin Resistance | DyslipidemiaAustralia
-
Arrowhead PharmaceuticalsActive, not recruitingMixed DyslipidemiaUnited States, Australia, Canada, New Zealand
-
AstraZenecaCompletedMetabolic Syndrome | DyslipidemiaAustralia
-
The University of Western AustraliaCompletedObesity | Insulin Resistance | DyslipidemiaAustralia
-
Resverlogix CorpSouth Australian Health and Medical Research InstituteTerminatedCoronary Artery Disease | DyslipidemiaAustralia
-
Arrowhead PharmaceuticalsActive, not recruitingDyslipidemiasUnited States, Australia, Canada, Poland, Netherlands, New Zealand, Hungary
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, United States, Australia
-
Bristol-Myers SquibbCompletedDyslipidemia | Diabetes Mellitus, Non-Insulin-DependentAustralia
-
Novartis PharmaceuticalsRecruitingMixed Dyslipidemia | Primary HypercholesterolemiaSwitzerland, Saudi Arabia, United Arab Emirates, United Kingdom, Austria, Israel, China, Malaysia
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHypercholesterolemia | Mixed DyslipidemiaAustria, United Kingdom, Italy, Germany, Belgium
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
SanofiCompletedObesity | DyslipidemiaUnited States, Canada, Brazil, Australia, Italy, Sweden, Malaysia, Singapore, Taiwan, Mexico, Denmark, Korea, Republic of, Hong Kong, South Africa
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
AmgenCompletedDyslipidemiaUnited States, Belgium, Denmark, Finland, France, Italy, Spain, Hungary, Poland, Germany, Czechia, Turkey, United Kingdom, Malaysia, Australia, Hong Kong, New Zealand, Canada, South Africa, Greece, Portugal, Netherlands, Russian Federation and more
-
AmgenCompletedDyslipidemiaUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Czechia, Hungary, Taiwan, Colombia, Poland, Russian Federation, Switzerland, Korea, Republic of, Mexico, ... and more
-
SanofiCompletedObesity | DyslipidemiaUnited States, Canada, Australia, Italy, Spain, Sweden, Switzerland, Finland
-
PfizerCompletedHyperlipidemiaKorea, Republic of, United States, Australia, Germany, Poland, Canada, Italy, Hong Kong, Czech Republic
-
Medical University of ViennaUnknown
-
Kirby InstituteNational Heart, Lung, and Blood Institute (NHLBI); St Vincent's Hospital, Sydney and other collaboratorsCompletedGlucose Metabolism Disorders | Metabolic Diseases | HIV Infections | Cardiovascular Disease | Dyslipidemias | LipodystrophyAustralia
-
SanofiRegeneron PharmaceuticalsCompletedDyslipidemiaUnited States, Australia, Brazil, Finland, Germany, Israel, Italy, Kuwait, Lebanon, Norway, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom
-
Swisse Wellness Pty LtdCommonwealth Scientific & Industrial Research Organisation; BIONAP SRLCompletedInvestigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults (CLoNE)HypercholesterolemiaAustralia
-
HighTide Biopharma Pty LtdCompletedHypercholesterolemiaAustralia
-
University of South AustraliaAmerican Egg BoardCompletedHypercholesterolemia | Hyperlipidemias | Diet, Healthy | Physical InactivityAustralia
-
Marea TherapeuticsRecruiting
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | HyperlipidemiaGreece, Austria, Finland, Italy, Hungary, Belgium, Spain, Ireland, Portugal, Slovenia, Switzerland
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia
-
The George InstitutePfizer; Royal Prince Alfred Hospital, Sydney, Australia; Lipid and Cardiovascular... and other collaboratorsCompletedHypercholesterolemiaAustralia
-
Moritz OberndorferMerck Gesellschaft mbH, AustriaCompletedHIV Infections | Diabetes Mellitus | Dyslipidemias | Cardiovascular Risk FactorAustria
-
The University of Western AustraliaNational Health and Medical Research Council, AustraliaUnknownFamilial Hypercholesterolaemia | HypertriglyceridaemiaAustralia
-
Affiris AGMedical University of ViennaCompleted
-
Medical University of GrazCompletedFluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular RiskHypercholesterolemiaAustria
-
Vaxxinity, Inc.Novotech (Australia) Pty LimitedActive, not recruiting
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyCompletedCardiovascular Diseases | Dyslipidemia | Hypercholesterolemia | Atherosclerotic Cardiovascular DiseaseFinland, Netherlands, Spain, Belgium, Sweden, Austria, United Kingdom, Switzerland, Denmark, France, Germany, Portugal, Italy, Ireland
-
Ikaria Bioscience Pty LtdRecruitingTo Reduce the LDL-C Level in Hypercholesteremia Adult Patients | Combination for Subgroup High LDL-c Patients With Other ComorbiditiesAustralia
-
Monash UniversityNational Health and Medical Research Council, AustraliaActive, not recruitingHeart Failure | Atrial Fibrillation | Hypercholesterolemia | Healthy AgeingAustralia
-
Western Sydney Local Health DistrictCompletedMetabolic Syndrome | HypercholesterolemiaAustralia
-
Hoffmann-La RocheCompletedCardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)China, United States, Spain, Netherlands, Canada, France, Mexico, Poland, Hungary, Australia, Denmark, United Kingdom, Czech Republic
-
AmgenCompletedSubjects With Hyperlipidemia, Dyslipidemia and HIV InfectionCanada, France, United States, Belgium, Italy, Spain, Switzerland, United Kingdom, South Africa, Portugal, Australia, Greece, Brazil, Romania, Poland
-
Unilever R&DCommonwealth Scientific and Industrial Research Organisation, AustraliaCompletedVascular Diseases | Diabetes Mellitus | HypercholesterolemiaAustralia
-
Mylan Inc.Mylan Österreich GmbH; Mylan Germany GmbH; Mylan Healthcare Sp. z o.o.CompletedHypercholesterolemiaGermany, Austria
-
Daiichi Sankyo, Inc.CompletedHypercholesterolemiaUnited States, South Africa, Israel, Netherlands, Canada, Norway, Austria, Australia
-
Glycemic Index Laboratories, IncUniversity of Toronto; University of Guelph; University of Sydney; Agriculture... and other collaboratorsCompletedHypercholesterolemiaCanada, Australia, United Kingdom
-
Arrowhead PharmaceuticalsCompletedHypertriglyceridemia | Familial ChylomicronemiaAustralia, Canada, New Zealand